Document is current
Any future updates will be listed below
-
Authors
Schacht, Joseph P. https://orcid.org/0000-0003-4250-0495
Hoffman, Michaela
Chen, Brian H.
Anton, Raymond F. https://orcid.org/0000-0003-3417-6576
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (R01 AA017633)
- License Information
-
More Information
Article History
Received: 10 December 2020
Revised: 27 July 2021
Accepted: 3 August 2021
First Online: 11 August 2021
Competing interests
: JPS reports that, in the past 3 years, he has consulted for and received grant funding from Laboratorio Farmaceutico CT. BHC is an employee of FOXO BioScience. RFA reports that, in the past three years, he has received grant funding from Laboratorio Farmaceutico CT and consulted for Allergan, Alkermes, Dicerna, Insys, and Life Epigenetics (FOXO BioScience). He is the Chair of the Alcohol Clinical Trials Initiative (ACTIVE), which is conducted under the auspices of the American Society for Clinical Psychopharmacology and funded (in the past 3 years) in part by Alkermes, Amygdala Neurosciences, Arbor Pharmaceuticals, Dicerna, Ethypharm, Indivior, Lundbeck, Mitsubishi, and Otsuka. MH reports no biomedical financial interests or potential conflicts of interest.
